PHILADELPHIA, PA — NRG Oncology, one of the five funded network groups within the National Cancer Institute (NCI)’s National Clinical Trials Network (NCTN), has announced that Robert S. Mannel, MD will serve as one of its three group chairmen effective September 1, 2017. He joins Drs. Walter J. Curran Jr. and Norman Wolmark as the NRG Oncology group chairmen and principal investigators of the group’s federal awards. He follows Philip J. DiSaia, MD in the role upon Dr. Disaia’s retirement after 46 years of outstanding service collectively to NRG Oncology and the Gynecologic Oncology Group (GOG) and his numerous contributions to ovarian cancer and gynecologic cancer research.

Read full press release here